These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2683226)

  • 21. EPA's control technology approach to assisting states and regions with air toxics problems: five case studies.
    Nolen SL; Dimmick WF
    Toxicol Ind Health; 1990 Oct; 6(5):257-67. PubMed ID: 2274989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic activity profiles--application in assessing potential carcinogenicity of complex environmental mixtures.
    Waters MD; Claxton LD; Stack HF; Graedel TE
    IARC Sci Publ; 1990; (104):75-88. PubMed ID: 2228145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms.
    Valavanidis A; Fiotakis K; Vlachogianni T
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(4):339-62. PubMed ID: 19034792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of short-term tests in detecting carcinogenicity of complex mixtures.
    Anderson D
    IARC Sci Publ; 1990; (104):89-100. PubMed ID: 2228146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To MTBE or not to MTBE.
    Environ Health Perspect; 1994 Nov; 102(11):913. PubMed ID: 9766950
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinogenic risk assessment of complex mixtures.
    Krewski D; Thorslund T; Withey J
    Toxicol Ind Health; 1989 Oct; 5(5):851-67. PubMed ID: 2683227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling population exposures to outdoor sources of hazardous air pollutants.
    Ozkaynak H; Palma T; Touma JS; Thurman J
    J Expo Sci Environ Epidemiol; 2008 Jan; 18(1):45-58. PubMed ID: 17878926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining occurrence and toxicity information to identify priorities for drinking-water mixture research.
    Ryker SJ; Small MJ
    Risk Anal; 2008 Jun; 28(3):653-66. PubMed ID: 18643823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives to the 2-species bioassay for the identification of potential human carcinogens.
    Ashby J
    Hum Exp Toxicol; 1996 Mar; 15(3):183-202. PubMed ID: 8839204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer risk assessment of 1,3-butadiene.
    Cote IL; Bayard SP
    Environ Health Perspect; 1990 Jun; 86():149-53. PubMed ID: 2205485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogen risk assessment in the U.S. Environmental Protection Agency.
    Albert RE
    Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogenic mixtures.
    Krewski D; Thomas RD
    Risk Anal; 1992 Mar; 12(1):105-13. PubMed ID: 1574610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment of inhaled chloroform based on its mode of action.
    Wolf DC; Butterworth BE
    Toxicol Pathol; 1997; 25(1):49-52. PubMed ID: 9061851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The history, genotoxicity and carcinogenicity of carbon-based fuels and their emissions: part 4 - alternative fuels.
    Claxton LD
    Mutat Res Rev Mutat Res; 2015; 763():86-102. PubMed ID: 25795115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.
    Mumtaz MM; George JD; Gold KW; Cibulas W; DeRosa CT
    Toxicol Ind Health; 1996; 12(6):742-971. PubMed ID: 9050165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Air pollution combustion emissions: characterization of causative agents and mechanisms associated with cancer, reproductive, and cardiovascular effects.
    Lewtas J
    Mutat Res; 2007; 636(1-3):95-133. PubMed ID: 17951105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioassay of complex mixtures of indoor air pollutants.
    Lewtas J; Claxton L; Mumford J; Lofroth G
    IARC Sci Publ; 1993; (109):85-95. PubMed ID: 8514373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.